在儿童过敏喘中,ADAM33的基因特异性微RNA介导调节
Xiang Wen1,2, Juan Zhou1,2,3,4, Heping Fang1,2
1Department of Respiratory Medicine, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing, China.
概括
在ADAM33中,一种特定的遗传变异 (SNP rs3918400) 通过改变微RNA调节来影响儿童喘风险. 这种单核酸多态性影响miR-3928-5p如何控制ADAM33,影响喘严重程度和呼吸道功能.
科学领域:
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
- 肺部病理学 肺部病理学
背景情况:
- 一种分解蛋白和金属蛋白酶33 (ADAM33) 与喘易感性和严重性有关.
- 在喘中ADAM33的作用背后的精确分子机制仍然不完全理解.
研究的目的:
- 调查ADAM33单核酸多态 (SNPs) 与儿童喘易感性的关联.
- 阐明涉及ADAM33SNP的调控机制及其对基因表达的影响.
主要方法:
- 11个ADAM33SNP的基因定型,以评估喘易感性.
- 在验证队列中测量了可溶性血ADAM33 (sADAM33) 水平和与喘严重程度的相关性.
- 微RNA (miRNA) 针对SNP的计算预测和实验验证以及它们对体外ADAM33表达的调节作用.
主要成果:
- SNP rs3918400与喘易感性有显著的相关性.
- 在患有过敏性喘的儿童和rs3918400CT/TT基因型儿童中观察到血sADAM33水平升高,与喘控制较差和呼吸道过敏反应增加相关.
- miR-3928-5p对rs3918400表现出基因特异性结合,对C基因更强的结合减少了ADAM33的表达,而对T基因更弱的结合减少了这种调节效应.
结论:
- rs3918400 SNP调节了miR-3928-5p在ADAM33.3.p上的负调节活动.
- 这种SNP-miRNA相互作用与复杂的遗传和分子途径有关,有助于儿童喘易感性和严重性.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
240
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
240
Asthma: Pathogenesis and Management
359
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
359
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
MicroRNAs
21.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.2K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K


